Malignant Lymphoma Fellowship Program
The goal of the Malignant Lymphoma Fellowship Program is to train Oncologist in the diagnosis and management of all types of Lymphoma. Each fellow will have had exposure to a variety of research programs and meet clinical and academic goals. At the completion of one year of training, the fellow is expected to be familiar with the natural history of Lymphoma, and to be knowledgeable about appropriate diagnostic and therapeutic approaches including autologous transplant and cellular immunotherapy (CAR T-cells).
- Elizabeth Budde, M.D., Ph.D., Associate Professor
- Alexey Danilov, M.D., Ph.D., Professor and Co-Director, Toni Stephenson Lymphoma Center
- Alex Herrera, M.D., Assistant Professor, Co-Director, Lymphoma Fellowship Program
- Matthew Mei, M.D., Associate Clinical Professor, Program Director, HCT/Cellular Therapy Fellowship Program, Co-Director, Lymphoma Fellowship Program
- Leslie Popplewell, M.D., Associate Clinical Professor
- Geoffrey Shouse, D.O., Ph.D., Assistant Clinical Professor
- Tanya Siddiqi, M.D., Associate Professor, Director, Chronic Lymphocytic Leukemia Program
- Jasmine Zain, M.D., Associate Clinical Professor, Director, T-Cell Lymphoma Program
- Swetha Kambhampati, July 2021 – June 2022.
Candidates should be eligible for California licensure. All applicants must be board certified in internal medicine, and board certified or board eligible in hematology/oncology.
Salary is commensurate with experience
Currently taking applications for the 2022 – 2023 fellowship year. Decision to be made in September and program will start in July.
Qualified applicants should send their CV, personal statement and three letters of recommendation to:
Hem/HCT Program Coordinator
City of Hope
1500 E. Duarte Rd.
Duarte, CA 91010